Tertiary healthcare service provider TalkMed Group says acquisitions discussions are “ongoing” in an update, according to a Sept 19 bourse filing.
This is the fifth update since the company’s board of directors first announced that it had received indications of “interests from persons who are considering acquisition of a stake in the company”.
The company’s board of directors add that “there is no assurance that a transaction will take place”.
Future announcements are expected to follow subject to material developments, says the board of directors.
On July 15, the company reported earnings of $8.6 million in 1HFY2024 ended June 30, down 31.1% y-o-y in 1HFY2023. Revenue in the same period was down 12.4% y-o-y at $33.1 million.
TalkMed was listed in 2014, with its IPO shares priced at 20 cents each. Its shares surged to an all-time high of 89 cents in 2017.
See also: Vitasoy ‘open to collaboration’ as speculation mounts over Philip Ng takeover
Shares in TalkMed closed 0.5 cents lower, or down 1.24%, at 40 cents on Sept 19.
